Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07817069) titled 'Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects' on Sept. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Faculty of Medicine, Sousse
Condition:
Treatment Resistant Schizophrenia
Obesity & Overweight
Abdominal Obesity
Intervention:
Dietary Supplement: The Nitraria retusa arm
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 3, 2026
Target Sample Size: 30
Countries of Recruitment:
Tunisia
To know more, visit https:/...